HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial

• Charlotta Nilsson ,

  * E-mail: charlotta.nilsson@folkhalsomyndigheten.se

  Affiliations Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden, Department of Microbiology, Tumor and Cell biology, Karolinska Institutet, Stockholm, Sweden, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden

  ⨯
• Bo Hejdeman,

  Affiliation Venhälsan, Department of Education and Clinical Research, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden

  ⨯
• Karina Godoy-Ramirez,

  Affiliation Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden

  ⨯
• Teghesti Tecleab,

  Affiliation Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden

  ⨯
• Gabriella Scarlatti,

  Affiliation Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and infectious diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy

  ⨯
• Andreas Bråve,

  Affiliation Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden

  ⨯
• Patricia L. Earl,

  Affiliation National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda MD, United States of America

  ⨯
• Richard R. Stout,

  Affiliation Bioject Inc., Tigard, Oregon, United States of America

  ⨯
• Merlin L. Robb,

  Affiliation Military HIV Research Program, Walter Reed Army Institute of Research, Rockville, Maryland, United States of America

  ⨯
• Robin J. Shattock,

  Affiliation Imperial College London, Department of Infectious Diseases, Division of Medicine, Norfolk Place, London, United Kingdom

  ⨯
• Gunnel Biberfeld,

  Affiliations Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden, Department of Microbiology, Tumor and Cell biology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Eric Sandström,

  Affiliation Venhälsan, Department of Education and Clinical Research, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden

  ⨯
• Britta Wahren

  Affiliation Department of Microbiology, Tumor and Cell biology, Karolinska Institutet, Stockholm, Sweden

  ⨯